• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人肝脏会诊病例中的疾病模式和实体突出了诊断性肝脏病理学实践中的具有挑战性的领域。

Disease patterns and entities in adult liver consult cases highlight challenging areas in diagnostic hepatopathology practice.

作者信息

Grypari Ioanna Maria, Vlachos Iakovos, Stoupi Eleni, Karandrea Despoina, Myoteri Despoina, Tiniakos Dina

机构信息

Department of Pathology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, 76 Vas. Sofias Avenue, Αthens, 11528, Greece.

Department of Pathology, General Hospital of Athens Ippokrateion, Athens, Greece.

出版信息

Virchows Arch. 2025 Aug 13. doi: 10.1007/s00428-025-04215-1.

DOI:10.1007/s00428-025-04215-1
PMID:40801927
Abstract

Difficult liver pathology cases often require expert review for optimal patient care. We reviewed consult cases received in our reference centre aiming to highlight challenging areas in hepatopathology that may benefit from specialist consultation and focused educational activities. We included all primary liver consult cases received between 10/2016 and 12/2022. Data on the sender and aetiology for consultation were collected. Initial and consult reports were screened for adequacy of clinical information, stains performed, final diagnosis and disease grading/staging. We retrieved 219 liver consults, 187 submitted by hepatologists. For medical cases, most common initial diagnoses were non-specific changes, chronic hepatitis and cirrhosis without underlying aetiology. Most common consult diagnoses were vascular disease, primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis (p < 0.001). Major change in initial diagnosis was noted in 72 (49%), minor change in 38 (25.9%) and no change in 23 (15.6%) cases. For focal liver lesions (n = 72), most common initial diagnoses were hepatocellular carcinoma (HCC), non-specific or metastatic. Most common consult diagnoses were HCC, cholangiocarcinoma or non-neoplastic liver (p = 0.033). Major change in initial diagnosis was noted in 30 (41.7%), minor change in 24 (33.3%) and no change in 15 (20.8%) cases. Study of liver consult patterns provides useful information on areas of hepatopathology posing diagnostic difficulty. Most challenging fields are vascular liver disease, interpretation of hepatitic pattern, primary cholangiopathy and classification and subtyping of hepatocellular tumours. These areas can be the subject for future medical educational activities in hepatopathology.

摘要

复杂的肝脏病理病例通常需要专家会诊以实现最佳的患者护理。我们回顾了在我们参考中心收到的会诊病例,旨在突出肝脏病理学中可能受益于专家会诊和针对性教育活动的具有挑战性的领域。我们纳入了2016年10月至2022年12月期间收到的所有原发性肝脏会诊病例。收集了关于发送者和会诊病因的数据。对初始报告和会诊报告进行筛选,以检查临床信息的充分性、所进行的染色、最终诊断以及疾病分级/分期。我们检索到219例肝脏会诊病例,其中187例由肝病学家提交。对于内科病例,最常见的初始诊断是非特异性改变、慢性肝炎和无潜在病因的肝硬化。最常见的会诊诊断是血管疾病、原发性胆汁性胆管炎和代谢功能障碍相关脂肪性肝炎(p<0.001)。72例(49%)病例的初始诊断有重大改变,38例(25.9%)有轻微改变,23例(15.6%)无改变。对于局灶性肝病变(n = 72),最常见的初始诊断是肝细胞癌(HCC)、非特异性或转移性病变。最常见的会诊诊断是HCC、胆管癌或非肿瘤性肝脏(p = 0.033)。30例(41.7%)病例的初始诊断有重大改变,24例(33.3%)有轻微改变,15例(20.8%)无改变。对肝脏会诊模式的研究为肝脏病理学中造成诊断困难的领域提供了有用信息。最具挑战性的领域是肝脏血管疾病、肝炎模式的解读、原发性胆管病以及肝细胞肿瘤的分类和亚型划分。这些领域可以成为未来肝脏病理学医学教育活动的主题。

相似文献

1
Disease patterns and entities in adult liver consult cases highlight challenging areas in diagnostic hepatopathology practice.成人肝脏会诊病例中的疾病模式和实体突出了诊断性肝脏病理学实践中的具有挑战性的领域。
Virchows Arch. 2025 Aug 13. doi: 10.1007/s00428-025-04215-1.
2
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
3
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
4
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
5
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study.数字病理学与光学显微镜检查在组织病理学切片诊断中的内部及相互间差异:双盲交叉对比研究
Health Technol Assess. 2025 Jul;29(30):1-75. doi: 10.3310/SPLK4325.
6
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.超声检查在酒精性肝病患者中对酒精性肝硬化的诊断作用
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
9
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
10
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.

本文引用的文献

1
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.成瘤融合蛋白 DNAJB1-PRKACA 可通过基于肽的免疫疗法在纤维板层肝细胞癌中进行特异性靶向治疗。
Nat Commun. 2022 Oct 27;13(1):6401. doi: 10.1038/s41467-022-33746-3.
2
Liver biopsy for assessment of chronic liver diseases: a synopsis.用于评估慢性肝病的肝活检:概述
Clin Exp Med. 2023 Jun;23(2):273-285. doi: 10.1007/s10238-022-00799-z. Epub 2022 Feb 22.
3
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
气球样变肝细胞特征识别的复杂性:为非酒精性脂肪性肝病基于人工智能的成像定义一个训练图谱。
J Hepatol. 2022 May;76(5):1030-1041. doi: 10.1016/j.jhep.2022.01.011. Epub 2022 Jan 25.
4
Evolution of the liver biopsy and its future.肝活检的发展历程及其未来。
Transl Gastroenterol Hepatol. 2021 Apr 5;6:20. doi: 10.21037/tgh.2020.04.01. eCollection 2021.
5
From the origin of NASH to the future of metabolic fatty liver disease.从非酒精性脂肪性肝炎的起源到代谢性脂肪肝病的未来。
Gut. 2021 Feb 25;70(8):1570-9. doi: 10.1136/gutjnl-2020-323202.
6
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology.英国胃肠病学会、皇家放射学院和皇家病理学院临床实践中肝活检使用指南。
Gut. 2020 Aug;69(8):1382-1403. doi: 10.1136/gutjnl-2020-321299. Epub 2020 May 28.
7
Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.分子靶向治疗:在胆管癌中准备“黄金时间”。
J Hepatol. 2020 Jul;73(1):170-185. doi: 10.1016/j.jhep.2020.03.007. Epub 2020 Mar 12.
8
Medical liver biopsy: background, indications, procedure and histopathology.医学肝脏活检:背景、适应证、操作及组织病理学
Frontline Gastroenterol. 2020 Jan;11(1):40-47. doi: 10.1136/flgastro-2018-101139. Epub 2019 Mar 2.
9
Idiopathic noncirrhotic portal hypertension.特发性非肝硬化性门静脉高压症。
Semin Diagn Pathol. 2019 Nov;36(6):395-403. doi: 10.1053/j.semdp.2019.07.006. Epub 2019 Jul 24.
10
Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns.肝血管肉瘤:临床病理特征和形态学模式。
Am J Surg Pathol. 2019 May;43(5):581-590. doi: 10.1097/PAS.0000000000001228.